Mediterrania Capital Partners, DEG, Proparco and FMO invest €75 million in Laprophan, one of the leading pharmaceutical companies in Morocco

por Mediterrania Capital Partners

Mediterrania Capital Partners is pleased to announce its acquisition of a stake in Laprophan – one of the leading pharmaceutical companies in Morocco –through its fund MC IV, alongside Germany’s...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Destacadas

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology

CRB Health Tech realiza el primer cierre...

by CRB Inverbío SA SGECR

Con la incorporación de Sanitas y las suscripciones ya firmadas con a...

Diapositiva de Fotos